VidBodh AcademyThe art and science of civil services preparation

Science and Technology › Health and disease

Drugs, diagnostics and medical technology

Drugs, diagnostics and medical devices, and the regulators and standards that keep them safe: drug approval and trials, the pharmacopoeia, substandard medicines, generics, prices and pharmacovigilance. It serves GS3 answers on science and technology in health.

11 Sep 2026 · 4 Aug 2026 · Prelims

Indian Pharmacopoeia Commission

A pharmacopoeia is the official book of standards a medicine must meet for identity, purity and strength, and India's is written by the Indian Pharmacopoeia Commission (IPC). Setting those standards is one half of the Commission's work; the other is watching what medicines and devices do once they are in use.

Indian Pharmacopoeia Commission
  • Works under

    • Ministry of Health and Family Welfare
  • Publishes

    • The Indian Pharmacopoeia, the official drug standards under the Drugs and Cosmetics Act, 1940
  • Runs

    • Pharmacovigilance Programme of India
    • Materiovigilance Programme of India
From the Press Information Bureau (PIB) releases of 4 August and 11 September 2026

11 Sep 2026 · Prelims

Enoxaparin sodium reference substance

Biological medicines such as heparins cannot be fully characterised chemically, so their strength is measured by bioassay rather than by chemical analysis. A bioassay is only as good as the sample it is compared against, and in September 2026 the Commission issued that sample for enoxaparin sodium.

  • The IPC released an Indian Pharmacopoeia Reference Substance (IPRS) for enoxaparin sodium bioassays.
  • An IPRS is the sample a laboratory measures a batch against, so a standard has a physical yardstick and not only a printed limit.
  • Enoxaparin sodium is a low molecular weight heparin, an anticoagulant used against thromboembolic disorders.

PIB, 11 Sep 2026: Indian Pharmacopoeia Commission (IPC) Organizes National Conference on Quality and Safety of Biosimilars: Strengthening India's Biopharma SHAKTI Vision (opens in a new tab)

4 Aug 2026 · Prelims

WHO South-East Asia Regulatory Network

The World Health Organization runs a regional network of drug regulators in South-East Asia, and it names national bodies to lead particular pieces of the work. Two of those designations now sit with the IPC.

  • The WHO South-East Asia Regulatory Network (SEARN) named the IPC its Regional Centre of Excellence in Pharmacovigilance.
  • The IPC is also the network's Technical Centre in Quality of Medicines.
  • The WHO South-East Asia Regional Office set up SEARN in 2016.

PIB, 4 Aug 2026: Indian Pharmacopoeia Commission named WHO-SEARN Centre of Excellence (opens in a new tab)